Skip to content
mielomamultiplo.com · Multiple Myeloma
Emergency 112  · SNS 24 808 24 24 24
The Multiple Myeloma symbol — find out what it means

Multiple Myeloma There is hope. There is a way forward.

information · support · hope

It is always better to be an informed patient.

News, testimonies, a space to share ideas and links that help patients and carers understand the disease better and know where to find help.

Automatic translation by MielomaAI. The original text is in Portuguese. Some parts may still appear in Portuguese while they are being translated. Português
Search the whole site

You can write in Portuguese, English, Spanish or French. The search doesn't link to accents or uppercase letters, separates the words (all must appear) and also searches for the equivalent word in other languages: "transplant" finds "transplant" and "trasplante". Searches in the original titles, translated titles into Portuguese, descriptions and abstracts. MielomaAI.

In the last 3 months. From the older news, only the title and link remain in the archive. Those that have about 1 year may no longer be up to date

Resultados para «biespecíficos» · 35

Looking for words: biespecificos. Saltar para: notícias recentes (19) · My Hematologia (3) · explanations (7) · arquivo (6)

Latest news from the last 3 months · 19

Click on an article to open it on the side with the summary. MielomaAI And the link to the source.

Summaries from My Hematologia · 3
Explanations on the website 7
Bispecifics
Antibodies with two “arms”: one grabs the T lymphocyte and the other the myeloma cell, joining them so that the lymphocyte destroys. Examples: teclistamab, elranatamab, talquetamab.
BCMA
The protein found on the surface of myeloma cells (B cell maturation antigen). It is the target of CAR-T Carvykti and the bispecific teclistamab and elranatamab.
This is a gene associated with multiple myeloma.
Another protein on myeloma cells, different from BCMA. It is the target of the bispecific talquetamab (Talvey).
T lymphocytes
White blood cells that attack cancerous cells. These are the ones that myeloma patients and specialists put to work attacking the myeloma, and these are used to manufacture CAR-T.
Cytokine release syndrome
Immune system reaction that can occur with CAR-T and bispecifics: fever, chills, low blood pressure. Almost always mild and treatable; therefore, initial doses are monitored.
ICANS
Effect on the brain of CAR-T and bispecifics: confusion, difficulty speaking or writing, drowsiness. Generally resolves, but must be reported promptly.
Extramedullary Disease
Multiple myeloma with tumors in organs or soft tissues (skin, liver, lymph nodes, nervous system), in diagnosis or, more frequently, in relapses. How it is managed or treated: Intensive treatment; CAR-T and bispecifics are options in relapse; clinical trials. Risk: High risk. See the film "Types of myeloma" →
In the file (over 3 months, just titles) · 6

Access and public health

Research

Treatments